Beckman Coulter Restructures, Shifts Sales Focus; Divestitures an Option | GenomeWeb

Beckman Coulter surprised investors last week with the announcement that it would restructure the company, lay off 350 employees — or 3 percent of its workforce — and shift its sales focus to leasing instrumentation rather than pursuing big-ticket purchases.

Beckman also said it will review "minor product lines, facilities, and other assets that do not support the one-company strategy," which could result in divestitures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.